Go to the list of all blogs
Alicia's Avatar
published in Blogs
May 05, 2026
BellRing Brands (BRBR) Shares Drop -43% After Earnings Miss and Guidance Cut

BellRing Brands (BRBR) Shares Drop -43% After Earnings Miss and Guidance Cut

Key Takeaways

  • BellRing Brands (BRBR) shares plunged 43.09% to $9.88 in the most recent trading session.
  • The primary catalyst was a disappointing Q2 fiscal 2026 earnings report, with adjusted EPS of $0.14 missing estimates of $0.31 by 55% and revenue of $598.7 million falling short of $608.8 million expectations.
  • Company cut its full-year 2026 revenue guidance to $2.33-$2.37 billion from prior $2.41-$2.46 billion, citing promotional headwinds, input cost inflation, and freight pressures.
  • Trading volume surged to over 12 million shares, well above the three-month average of 3.56 million.
  • The move diverged sharply from consumer staples peers and the XLP ETF, which showed minimal change.
  • Traders are watching the earnings conference call for further commentary on margin pressures and recovery plans.

The Sharp Decline in BRBR Shares

BellRing Brands, Inc. (BRBR), known for its convenient nutrition products such as Premier Protein shakes and Dymatize powders, experienced a significant drop in its stock price. Shares fell 43.09% to $9.88 during Monday's trading session, down from a prior close of $17.36. This reaction stemmed directly from the company's second-quarter fiscal 2026 earnings miss and a downward revision to its full-year guidance. From what I see, investors are clearly concerned about slowing growth and profitability pressures in the protein nutrition segment.

Breaking Down the Earnings Miss and Revised Outlook

In Q2 fiscal 2026, BellRing Brands reported net sales of $598.7 million, reflecting just a 1.8% year-over-year increase but missing the consensus estimate of $598.8 million. Adjusted EPS came in at $0.14, representing a 55.3% shortfall against expectations of $0.31. One thing that stands out is the sharp contraction in gross margins, which fell to 22.7% from 34.5% a year earlier, driven by higher protein and freight costs along with increased promotional activity.

The company also adjusted its fiscal 2026 outlook, narrowing revenue guidance to $2.33-$2.37 billion—about 2.9% below prior analyst forecasts—and Adjusted EBITDA to $315-$335 million. Management pointed to ongoing consumer headwinds, inflation on key inputs, and investments in advertising as key factors, noting that the guidance does not assume recovery from recent inventory issues. I also checked this using Tickeron’s AI Screener to see how BRBR compares to others in the industry, and the margin pressures appear more acute here.

Trading Volume and Market Reaction

Trading volume spiked to 12 million shares, more than triple the three-month average of 3.56 million, indicating strong selling pressure following the earnings release. This plunge stood out against the broader market and sector, where the Consumer Staples Select Sector SPDR ETF (XLP) remained flat around $83.64. Among peers, Post Holdings (POST) dipped slightly to $102.09, Monster Beverage (MNST) edged up to $76.27, and USANA Health (USNA) held near $18.60, highlighting the company-specific nature of BRBR's decline. Technically, shares broke below key support near $17, with heightened volatility despite a beta of 0.81.

Exploring Tickeron’s Trending AI Robots

In my own research process, I often turn to Tickeron’s Trending AI Robots page, which highlights the platform's top-performing AI-driven trading bots tailored to current market conditions. Tickeron provides hundreds of these AI bots, covering thousands of tickers across strategies like momentum, mean reversion, and pattern recognition, across various timeframes and performance metrics. Only the strongest, most adaptive ones make the curated list, which is particularly useful in volatile situations like earnings-driven moves. I’m watching this closely because it helps me identify tools that deliver data-backed insights without relying on guesswork—check out the real-time rankings, backtested results, and bot details there for yourself.

Looking Ahead for BRBR

Investors will want to tune into the Q2 earnings conference call at 8:30 a.m. ET for more details on cost management and demand trends. The next quarterly results are scheduled for early August 2026. In my view, analyst consensus is turning cautious after the guidance cut, with emphasis on execution in a competitive protein category. Broader sector risks persist, including inflation and shifting consumer preferences toward value options. Uncertainties around promotional effectiveness and supply chain costs remain, though long-term potential exists in household penetration for ready-to-drink nutrition if margins can stabilize. This is important because it underscores the need for disciplined monitoring.

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

Related Ticker: BRBR

Contributor

Alicia's AvatarAlicia|Beginner

BRBR's Indicator enters downward trend

The Aroon Indicator for BRBR entered a downward trend on August 11, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 193 similar instances where the Aroon Indicator formed such a pattern. In of the 193 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BRBR as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for BRBR turned negative on July 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

BRBR moved below its 50-day moving average on August 12, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BRBR crossed bearishly below the 50-day moving average on August 17, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BRBR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BRBR's RSI Indicator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BRBR advanced for three days, in of 296 cases, the price rose further within the following month. The odds of a continued upward trend are .

BRBR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (8.481). P/E Ratio (7.176) is within average values for comparable stocks, (36.558). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.944). BRBR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.055). P/S Ratio (0.518) is also within normal values, averaging (5.907).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BRBR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BRBR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

Notable companies

The most notable companies in this group are Kraft Heinz Company (The) (NASDAQ:KHC), General Mills (NYSE:GIS), The Campbell's Company (NASDAQ:CPB), Beyond Meat Inc. (NASDAQ:BYND).

Industry description

Companies in this industry usually make a diverse range of agricultural and/or processed food. Some prominent names in this segment are Mondelez International, which makes chocolates, biscuits, cookies etc. The Kraft Heinz Company specializes in ketchups, sauces, fruit drink pouches and many more. General Mills, Inc. sells flour and cereal. Kellogg is famous for its snacks and breakfast cereal. And so on down the line. As more and more consumers are looking for healthier options in food in recent years, several legacy food companies have responded by revamping brands to include organic and no-added-sugar versions, and/or acquiring healthy food firms, and even streamlining operations.

Market Cap

The average market capitalization across the Food: Major Diversified Industry is 3.33B. The market cap for tickers in the group ranges from 68.52K to 255.67B. NSRGY holds the highest valuation in this group at 255.67B. The lowest valued company is THRC at 68.52K.

High and low price notable news

The average weekly price growth across all stocks in the Food: Major Diversified Industry was 0%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was -8%. BRLS experienced the highest price growth at 114%, while BRCC experienced the biggest fall at -90%.

Volume

The average weekly volume growth across all stocks in the Food: Major Diversified Industry was 14%. For the same stocks of the Industry, the average monthly volume growth was -8% and the average quarterly volume growth was -28%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 61
Price Growth Rating: 59
SMR Rating: 78
Profit Risk Rating: 91
Seasonality Score: -16 (-100 ... +100)
View a ticker or compare two or three
BRBR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry FoodMajorDiversified

Profile
Details
Industry
N/A
Address
2503 S. Hanley Road
Phone
+1 314 644-7600
Employees
420
Web
https://www.bellring.com
Interact to see
Advertisement
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.